HIM
ACIU icon

Hillhouse Investment Management’s AC Immune ACIU Stock Holding History

Hillhouse Investment Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-550,000
Closed -$4.84M – 49
2017
Q2 		$4.84M Hold
550,000
– – 0.07% 48
2017
Q1 		$5.7M Hold
550,000
– – 0.11% 41
2016
Q4 		$7.14M Hold
550,000
– – 0.16% 24
2016
Q3 		$9.06M Buy
+550,000
New +$9.5M 0.19% 25

Other funds holding ACIU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return

Hillhouse Investment Management's ACIU Position: Q3 2017 in Review

Hillhouse Investment Management sold out of AC Immune (ACIU) in Q3 2017, closing a stake of 550,000 shares — an estimated $4.84M sold.

Hillhouse Investment Management first reported a position in ACIU in Q3 2016 and held it in 4 quarters. The position peaked at $9.06M in Q3 2016. 15 funds tracked by Wall St. Rank hold ACIU as of Q3 2017.

  • Hillhouse Investment Management reported no remaining AC Immune position as of Q3 2017 after selling out during the quarter.
  • Hillhouse Investment Management sold 550,000 AC Immune shares in Q3 2017, an estimated $4.84M.
  • Hillhouse Investment Management first reported a position in AC Immune in Q3 2016 and held it in 4 quarters.
  • Hillhouse Investment Management's AC Immune position peaked at $9.06M in Q3 2016.
  • 15 funds tracked by Wall St. Rank held AC Immune as of Q3 2017.

Based on Hillhouse Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.